<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04212572</url>
  </required_header>
  <id_info>
    <org_study_id>MASAI (29BRC19.0103)</org_study_id>
    <nct_id>NCT04212572</nct_id>
  </id_info>
  <brief_title>Ultrasound Abnormalities of the Salivary Glands in Primary Sjögren's Syndrome According to the Duration of the Disease</brief_title>
  <acronym>MASAÏ</acronym>
  <official_title>Ultrasound Abnormalities of the Salivary Glands in Primary Sjögren's Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Brest</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Brest</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Salivary gland ultrasonography is identified as a valuable diagnostic tool and potential
      criteria item for disease classification of sjögren's syndrome and evaluate evolution of
      parenchyma.

      The investigators have to include 242 patients. The objective is to evaluate the modification
      of ultrasonographic abnormalities according to disease in primary Sjögren syndrome.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 20, 2019</start_date>
  <completion_date type="Anticipated">May 20, 2020</completion_date>
  <primary_completion_date type="Anticipated">May 20, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Presence or absence of parenchymal abdnormalities.</measure>
    <time_frame>inclusion</time_frame>
    <description>Presence or absence of parenchymal abdnormalities. Scored following a standardized fill and according to disease duration</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Parenchymal abnormalities according to disease activity</measure>
    <time_frame>inclusion</time_frame>
    <description>Ultrasonography parenchymal abnormalities of salivary gland</description>
  </secondary_outcome>
  <enrollment type="Anticipated">242</enrollment>
  <condition>Primary sjögren's Syndrome</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Primary sjögren syndrome
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female patient ≥ 18 years

          -  Primary sjögren syndrome according of age to 2002 or 2016 classification criteria

        Exclusion Criteria:

          -  Secondary sjögren syndrome
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Valerie DEVAUCHELLE</last_name>
    <phone>2 98 34 72 64</phone>
    <email>valerie.devauchelle-pensec@chu-brest.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHRU de Brest</name>
      <address>
        <city>Brest</city>
        <zip>29609</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valerie Devauchelle</last_name>
      <phone>02 98 34 72 64</phone>
      <email>valerie.devauchelle-pensec@chu-brest.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de LILLE</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Eric Hachulla</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de MONTEPELLIER</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jacques MOREL</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 19, 2019</study_first_submitted>
  <study_first_submitted_qc>December 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 27, 2019</study_first_posted>
  <last_update_submitted>December 26, 2019</last_update_submitted>
  <last_update_submitted_qc>December 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 27, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Primary sjögren's syndrome</keyword>
  <keyword>ultrasonography</keyword>
  <keyword>salivary glands</keyword>
  <keyword>auto-immune disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sjogren's Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All collected data that underlie results in a publication</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>Data will be available beginning one year and ending two years following the publication</ipd_time_frame>
    <ipd_access_criteria>Data access requests will be reviewed by the internal committee of Brest UH. Requestors will be required to sign and complete a data access agreement.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

